Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs OMKAR PHARMACHEM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA OMKAR PHARMACHEM BAL PHARMA/
OMKAR PHARMACHEM
 
P/E (TTM) x 40.8 115.1 35.5% View Chart
P/BV x 2.3 2.5 90.2% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 BAL PHARMA   OMKAR PHARMACHEM
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
OMKAR PHARMACHEM
Mar-23
BAL PHARMA/
OMKAR PHARMACHEM
5-Yr Chart
Click to enlarge
High Rs13425 536.4%   
Low Rs6319 327.6%   
Sales per share (Unadj.) Rs193.90.5 36,193.1%  
Earnings per share (Unadj.) Rs1.70.2 849.8%  
Cash flow per share (Unadj.) Rs7.50.2 3,755.0%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs40.79.0 453.1%  
Shares outstanding (eoy) m15.6910.08 155.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.541.4 1.2%   
Avg P/E ratio x59.2113.1 52.3%  
P/CF ratio (eoy) x13.2111.5 11.8%  
Price / Book Value ratio x2.42.5 98.2%  
Dividend payout %59.90-   
Avg Mkt Cap Rs m1,549224 692.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5531 39,782.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0425 56,336.3%  
Other income Rs m90 31,366.7%   
Total revenues Rs m3,0525 56,198.3%   
Gross profit Rs m2533 8,119.0%  
Depreciation Rs m910 304,266.7%   
Interest Rs m1230 26,200.0%   
Profit before tax Rs m473 1,792.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m211 3,177.6%   
Profit after tax Rs m262 1,322.7%  
Gross profit margin %8.357.6 14.4%  
Effective tax rate %44.825.2 178.1%   
Net profit margin %0.936.6 2.4%  
BALANCE SHEET DATA
Current assets Rs m2,2823 87,082.4%   
Current liabilities Rs m2,0937 30,515.2%   
Net working cap to sales %6.2-78.5 -7.9%  
Current ratio x1.10.4 285.4%  
Inventory Days Days86,286 0.1%  
Debtors Days Days1,128876 128.7%  
Net fixed assets Rs m82993 890.5%   
Share capital Rs m157101 155.6%   
"Free" reserves Rs m481-10 -4,624.9%   
Net worth Rs m63890 705.3%   
Long term debt Rs m3050-   
Total assets Rs m3,11096 3,251.2%  
Interest coverage x1.46.6 20.9%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.00.1 1,732.8%   
Return on assets %4.82.6 187.8%  
Return on equity %4.12.2 187.7%  
Return on capital %18.13.4 525.6%  
Exports to sales %66.40-   
Imports to sales %22.40-   
Exports (fob) Rs m2,020NA-   
Imports (cif) Rs m683NA-   
Fx inflow Rs m2,0200-   
Fx outflow Rs m7160-   
Net fx Rs m1,3050-   
CASH FLOW
From Operations Rs m-183 -668.1%  
From Investments Rs m-222NA-  
From Financial Activity Rs m244-4 -6,873.2%  
Net Cashflow Rs m4-1 -473.4%  

Share Holding

Indian Promoters % 47.1 0.0 156,966.7%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 100.0 48.8%  
Shareholders   15,060 3,600 418.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs OMKAR PHARMACHEM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs OMKAR PHARMACHEM Share Price Performance

Period BAL PHARMA OMKAR PHARMACHEM S&P BSE HEALTHCARE
1-Day -4.40% 0.00% 1.18%
1-Month -17.76% 3.21% -0.75%
1-Year 40.93% -10.08% 61.82%
3-Year CAGR 19.04% 4.50% 18.16%
5-Year CAGR 5.43% 10.90% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the OMKAR PHARMACHEM share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of OMKAR PHARMACHEM the stake stands at 0.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of OMKAR PHARMACHEM.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

OMKAR PHARMACHEM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of OMKAR PHARMACHEM.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.